|
|
Blood, 15 February 2004, Vol. 103, No. 4, pp. 1499-1502.
Prepublished online as a Blood First Edition Paper on October 23, 2003; DOI 10.1182/blood-2003-07-2446.

Submitted July 21, 2003
Accepted September 24, 2003
Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome
Norbert Gattermann*, Michael Wulfert, Baerbel Junge, Ulrich Germing, Rainer Haas, and Goetz Hofhaus
Haematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, NRW, Germany
Institute of Biochemistry, Heinrich-Heine-University, Duesseldorf, NRW, Germany
* Corresponding author; email: gattermann{at}med.uni-duesseldorf.de.
In a patient with refractory anemia with excess blasts (RAEB), a somatic mutation of mitochondrial transfer RNALeu(UUR) was detected in bone marrow cells. Heteroduplex analysis indicated that 40-50 percent of mitochondrial DNA (mtDNA) molecules in the bone marrow (BM) carried the novel G3242A mutation. The proportion of mutant mtDNA was higher in CD34+ cells than in the unfractionated sample. Surprisingly, the mutation was not detectable by heteroduplex analysis in the peripheral blood (PB). However, peripheral blood CD34+ cells selected by immunomagnetic beads harboured the mutation with a proportion of approximately 50%. In hematopoietic colony assays, CD34+ cells from BM and PB yielded only colonies with wildtype mtDNA. These results indicate that the mtDNA mutation in CD34+ cells was associated with a maturation defect. Mitochondrial tRNA mutations impair mitochondrial protein synthesis, thereby causing dysfunction of the mitochondrial respiratory chain. We propose that this effect contributed to ineffective hematopoiesis in our patient.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
The myelodysplastic syndromes: heterogeneneity on many levels
- Peter T. Curtin
Blood 2004 103: 1181-1182.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Chen, T. D. Logan, M. L. Hochberg, S. G. Shelat, X. Yu, G. E. Wilding, W. Tan, G. C. Kujoth, T. A. Prolla, M. A. Selak, et al.
Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction
Blood,
November 5, 2009;
114(19):
4045 - 4053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hellstrom-Lindberg and M. Cazzola
The Role of JAK2 Mutations in RARS and Other MDS
Hematology,
January 1, 2008;
2008(1):
52 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Steensma and A. F. List
Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic Diversity
Mayo Clin. Proc.,
May 1, 2005;
80(5):
681 - 698.
[Abstract]
[PDF]
|
 |
|
|
|